Literature DB >> 21484869

Movement disorders in adult surviving patients with maple syrup urine disease.

Miryam Carecchio1, Susanne A Schneider, Heidi Chan, Robin Lachmann, Philip J Lee, Elaine Murphy, Kailash P Bhatia.   

Abstract

Maple syrup urine disease is a rare metabolic disorder caused by mutations in the branched-chain α-keto acid dehydrogenase complex gene. Patients generally present early in life with a toxic encephalopathy because of the accumulation of the branched-chain amino acids leucine, isoleucine, and valine and the corresponding ketoacids. Movement disorders in maple syrup urine disease have typically been described during decompensation episodes or at presentation in the context of a toxic encephalopathy, with complete resolution after appropriate dietary treatment. Movement disorders in patients surviving childhood are not well documented. We assessed 17 adult patients with maple syrup urine disease (mean age, 27.5 years) with a special focus on movement disorders. Twelve (70.6%) had a movement disorder on clinical examination, mainly tremor and dystonia or a combination of both. Parkinsonism and simple motor tics were also observed. Pyramidal signs were present in 11 patients (64.7%), and a spastic-dystonic gait was observed in 6 patients (35.2%). In summary, movement disorders are common in treated adult patients with maple syrup urine disease, and careful neurological examination is advisable to identify those who may benefit from specific therapy. © 2011 Movement Disorder Society.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21484869      PMCID: PMC4235248          DOI: 10.1002/mds.23629

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  LATE MANIFESTING VARIANT OF BRANCHED-CHAIN KETOACIDURIA (MAPLE SYRUP URINE DISEASE).

Authors:  R KIIL; T ROKKONES
Journal:  Acta Paediatr       Date:  1964-07       Impact factor: 2.299

2.  Variant maple syrup urine disease (MSUD)--the entire spectrum.

Authors:  E Simon; N Flaschker; P Schadewaldt; U Langenbeck; U Wendel
Journal:  J Inherit Metab Dis       Date:  2006-10-25       Impact factor: 4.982

3.  Neuropsychometric outcome predictors for adults with maple syrup urine disease.

Authors:  C le Roux; E Murphy; P Hallam; M Lilburn; D Orlowska; P Lee
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

4.  Disappearance of self-mutilating behavior in a patient with lesch-nyhan syndrome after bilateral chronic stimulation of the globus pallidus internus. Case report.

Authors:  Takaomi Taira; Tomonori Kobayashi; Tomokatsu Hori
Journal:  J Neurosurg       Date:  2003-02       Impact factor: 5.115

Review 5.  Cerebellar involvement in metabolic disorders: a pattern-recognition approach.

Authors:  M Steinlin; S Blaser; E Boltshauser
Journal:  Neuroradiology       Date:  1998-06       Impact factor: 2.804

6.  Antero-ventral internal pallidum stimulation improves behavioral disorders in Lesch-Nyhan disease.

Authors:  Laura Cif; Brigitte Biolsi; Sophie Gavarini; Aude Saux; Santiago Gil Robles; Cornel Tancu; Xavier Vasques; Philippe Coubes
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338

Review 7.  Involvement of basal ganglia transmitter systems in movement initiation.

Authors:  W Hauber
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

8.  Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients.

Authors:  I Trender-Gerhard; M G Sweeney; P Schwingenschuh; P Mir; M J Edwards; A Gerhard; J M Polke; M G Hanna; M B Davis; N W Wood; K P Bhatia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-03-29       Impact factor: 10.154

9.  Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.

Authors:  William J Zinnanti; Jelena Lazovic; Kathleen Griffin; Kristen J Skvorak; Harbhajan S Paul; Gregg E Homanics; Maria C Bewley; Keith C Cheng; Kathryn F Lanoue; John M Flanagan
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

10.  Parkin disease: a phenotypic study of a large case series.

Authors:  Naheed L Khan; Elizabeth Graham; Peter Critchley; Anette E Schrag; Nicholas W Wood; Andrew J Lees; Kailash P Bhatia; Niall Quinn
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

View more
  17 in total

Review 1.  Genetic updates on paroxysmal dyskinesias.

Authors:  James Y Liao; Philippe A Salles; Umar A Shuaib; Hubert H Fernandez
Journal:  J Neural Transm (Vienna)       Date:  2021-04-30       Impact factor: 3.575

2.  Clinical approach to Parkinson's disease: features, diagnosis, and principles of management.

Authors:  João Massano; Kailash P Bhatia
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

Review 3.  Treatable inherited rare movement disorders.

Authors:  H A Jinnah; Alberto Albanese; Kailash P Bhatia; Francisco Cardoso; Gustavo Da Prat; Tom J de Koning; Alberto J Espay; Victor Fung; Pedro J Garcia-Ruiz; Oscar Gershanik; Joseph Jankovic; Ryuji Kaji; Katya Kotschet; Connie Marras; Janis M Miyasaki; Francesca Morgante; Alexander Munchau; Pramod Kumar Pal; Maria C Rodriguez Oroz; Mayela Rodríguez-Violante; Ludger Schöls; Maria Stamelou; Marina Tijssen; Claudia Uribe Roca; Andres de la Cerda; Emilia M Gatto
Journal:  Mov Disord       Date:  2017-09-01       Impact factor: 10.338

4.  Serum Markers of Neurodegeneration in Maple Syrup Urine Disease.

Authors:  Giselli Scaini; Tássia Tonon; Carolina F Moura de Souza; Patricia F Schuk; Gustavo C Ferreira; Joao Seda Neto; Tatiana Amorin; Ida Vanessa D Schwartz; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 5.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

6.  An integrative tissue-network approach to identify and test human disease genes.

Authors:  Victoria Yao; Rachel Kaletsky; William Keyes; Danielle E Mor; Aaron K Wong; Salman Sohrabi; Coleen T Murphy; Olga G Troyanskaya
Journal:  Nat Biotechnol       Date:  2018-10-22       Impact factor: 54.908

Review 7.  Maple syrup urine disease: mechanisms and management.

Authors:  Patrick R Blackburn; Jennifer M Gass; Filippo Pinto E Vairo; Kristen M Farnham; Herjot K Atwal; Sarah Macklin; Eric W Klee; Paldeep S Atwal
Journal:  Appl Clin Genet       Date:  2017-09-06

8.  Loss of the Drosophila branched-chain α-ketoacid dehydrogenase complex results in neuronal dysfunction.

Authors:  Hui-Ying Tsai; Shih-Cheng Wu; Jian-Chiuan Li; Yu-Min Chen; Chih-Chiang Chan; Chun-Hong Chen
Journal:  Dis Model Mech       Date:  2020-08-27       Impact factor: 5.758

9.  Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease.

Authors:  Kara R Vogel; Erland Arning; Brandi L Wasek; Sterling McPherson; Teodoro Bottiglieri; K Michael Gibson
Journal:  Orphanet J Rare Dis       Date:  2014-05-08       Impact factor: 4.123

Review 10.  Parkinsonism in Inherited Metabolic Disorders: Key Considerations and Major Features.

Authors:  Nattakarn Limphaibool; Piotr Iwanowski; Marte Johanne Veilemand Holstad; Katarzyna Perkowska
Journal:  Front Neurol       Date:  2018-10-12       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.